Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-May-16 12:45 PM View:  | Impax Laboratories, LLC (IPXL) | 29-Apr-16 | Payment of Exercise | 61,594 | $33.35 | $2,054,160.00 | (12%) 526.46K to 464.86K | 45% |
| 01-Mar-16 4:10 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-16 | Grant | 89,332 | -- | -- | 20% 442.69K to 532.02K | |
| 01-Mar-16 4:10 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-16 | Payment of Exercise | 5,567 | $33.27 | $185,214.00 | (1%) 532.02K to 526.46K | 45% |
| 30-Oct-15 2:06 PM View: | Impax Laboratories, LLC (IPXL) | 29-Oct-15 | Payment of Exercise | 16,425 | $35.75 | $587,194.00 | (4%) 459.12K to 442.69K | 49% |
| 01-May-15 3:14 PM View: | Impax Laboratories, LLC (IPXL) | 29-Apr-15 | Payment of Exercise | 114,803 | $46.36 | $5,322,270.00 | (20%) 573.92K to 459.12K | 61% |
| 12-Mar-15 2:31 PM View: | Impax Laboratories, LLC (IPXL) | 26-Feb-15 | Grant | 68,000 | -- | -- | 13% 505.92K to 573.92K | |
| 31-Oct-14 12:39 PM View: | Impax Laboratories, LLC (IPXL) | 29-Oct-14 | Payment of Exercise | 19,081 | $28.19 | $537,893.00 | (4%) 525.0K to 505.92K | 35% |
| 08-May-14 1:15 PM View: | Impax Laboratories, LLC (IPXL) | 06-May-14 | Grant | 525,000 | -- | -- | 100% 0 to 525.0K | |
| 02-Dec-13 6:09 PM View: | Allergan Plc (AGN) | 27-Nov-13 | Market Sale | 24,217 | $165.00 | $3,995,800.00 | (61%) 39.63K to 15.41K | 12% |
| 26-Nov-13 5:42 PM View: | Allergan Plc (AGN) | 25-Nov-13 | Market Sale | 1,502 | $165.00 | $247,830.00 | (4%) 41.13K to 39.63K | 12% |
| 26-Nov-13 5:42 PM View: | Allergan Plc (AGN) | 22-Nov-13 | Market Sale | 4,281 | $165.00 | $706,365.00 | (9%) 45.41K to 41.13K | 12% |
| 02-Oct-13 9:17 PM View: | Watson Pharmaceuticals Inc. (ACT) | 01-Oct-13 | Disposition | 45,412 | -- | -- | (100%) 45.41K to 0 | |
| 03-Oct-13 4:34 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 45,412 | -- | -- | 100% 0 to 45.41K | |
| 02-Oct-13 9:17 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Grant | 39,612 | -- | -- | 80% 49.23K to 88.84K | |
| 02-Oct-13 9:17 PM View: | Watson Pharmaceuticals Inc. (ACT) | 30-Sep-13 | Payment of Exercise | 43,429 | $144.00 | $6,253,780.00 | (49%) 88.84K to 45.41K | 83% |
| 24-Sep-13 6:01 PM View: | Watson Pharmaceuticals Inc. (ACT) | 21-Sep-13 | Payment of Exercise | 3,240 | $135.50 | $439,020.00 | (6%) 52.47K to 49.23K | 82% |
| 06-Sep-13 4:05 PM View: | Watson Pharmaceuticals Inc. (ACT) | 04-Sep-13 | Market Sale | 16,749 | $138.00 | $2,311,360.00 | (24%) 69.22K to 52.47K | 83% |
| 08-Mar-13 6:24 PM View: | Watson Pharmaceuticals Inc. (ACT) | 06-Mar-13 | Grant | 14,085 | -- | -- | 26% 55.13K to 69.22K | |
| 05-Mar-13 7:26 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-13 | Payment of Exercise | 5,554 | $85.54 | $475,089.00 | (9%) 60.69K to 55.13K | 72% |
| 02-Nov-12 12:53 PM View: | Watson Pharmaceuticals Inc. (ACT) | 31-Oct-12 | Grant | 2,909 | -- | -- | 5% 57.78K to 60.69K | |
| 12-Mar-12 2:33 PM View: | Watson Pharmaceuticals Inc. (ACT) | 08-Mar-12 | Grant | 17,154 | -- | -- | 42% 40.62K to 57.78K | |
| 28-Feb-12 12:25 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-12 | Payment of Exercise | 1,956 | $58.17 | $113,781.00 | (5%) 42.58K to 40.62K | 61% |
| 22-Sep-11 4:40 PM View: | Watson Pharmaceuticals Inc. (ACT) | 21-Sep-11 | Payment of Exercise | 2,028 | $70.04 | $142,041.00 | (5%) 44.61K to 42.58K | 68% |
| 04-Mar-11 4:51 PM View: | Watson Pharmaceuticals Inc. (ACT) | 02-Mar-11 | Grant | 18,040 | -- | -- | 68% 26.57K to 44.61K | |
| 26-Feb-10 4:33 PM View: | Watson Pharmaceuticals Inc. (ACT) | 24-Feb-10 | Grant | 12,008 | -- | -- | 82% 14.56K to 26.57K | |
| 22-Sep-09 4:48 PM View: | Watson Pharmaceuticals Inc. (ACT) | 21-Sep-09 | Grant | 12,500 | -- | -- | 607% 2.06K to 14.56K |